Equities
  • Price (CHF)321.10
  • Today's Change1.90 / 0.60%
  • Shares traded23.20k
  • 1 Year change+42.14%
  • Beta1.3787
Data delayed at least 15 minutes, as of Nov 05 2024 13:21 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sonova Holding AG is a Switzerland-based company operating in the healthcare sector. The Company, along with its subsidiaries, designs, develops, manufactures, distributes and services hearing systems for adults and children with hearing impairment. The Company is active in two operating segments: the Hearing instruments segment includes the companies that are active in the design, development, manufacture, distribution and service of hearing instruments and related products, and the Cochlear implants segment includes the companies that are active in the design, development, manufacture, distribution and service of hearing implants and related products. It operates worldwide and distributes its products in over 90 countries through its own distribution network and through independent distributors. Sonova Holding AG is the holding company of the Sonova Group and operates the wholly owned subsidiaries Comfort Audio GmbH and Hansaton Akustik GmbH.

  • Revenue in CHF (TTM)3.63bn
  • Net income in CHF601.00m
  • Incorporated1985
  • Employees18.15k
  • Location
    Sonova Holding AGLaubisruetistrasse 28STAEFA 8712SwitzerlandCHE
  • Phone+41 589283333
  • Fax+41 589283345
  • Websitehttps://www.sonova.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioMerieux SA3.58bn386.61m11.45bn14.65k29.723.1417.273.203.463.4632.0432.800.73561.825.63259,811.607.719.309.5712.3155.7256.5110.4812.381.20236.140.125817.762.398.70-20.956.878.3619.42
Sartorius AG3.12bn78.21m15.08bn13.76k154.744.8630.824.831.221.2248.6638.730.33651.849.34227,432.601.378.211.7311.8343.9550.934.0614.151.132.410.54519.59-18.6616.74-69.747.7419.143.66
Sartorius Stedim Biotech SA2.58bn159.04m17.42bn10.38k106.304.7740.586.751.791.7929.2239.950.41451.758.84257,644.002.6111.873.0415.1241.8250.966.3117.441.032.950.426618.73-20.5318.02-64.658.2821.823.90
Straumann Holding AG2.47bn307.19m18.78bn11.15k61.139.5442.037.611.931.7015.4712.340.7151.764.21222,176.908.9510.6811.8413.6372.7674.9512.5215.151.5513.150.18737.503.9212.08-43.40-2.0411.5410.12
Sonova Holding AG3.63bn601.00m19.03bn18.15k31.777.7022.245.2510.0510.0560.6641.440.63942.356.82199,818.2010.7510.8713.4513.8872.2871.9716.8017.771.0731.440.426835.21-2.985.59-5.845.771.758.20
Koninklijke Philips NV16.96bn-440.85m22.11bn69.28k----33.411.30-0.4847-0.33519.14--------258,972.70--0.3678--0.501342.1843.84-2.590.6049--5.35----1.920.052971.87---5.24--
Coloplast A/S3.32bn626.06m23.53bn16.02k40.1912.0930.127.1022.1022.10117.8673.490.62882.365.911,676,204.0011.8720.4516.1929.6967.5267.9118.8821.730.558710.600.597591.088.518.291.644.4613.155.59
Data as of Nov 05 2024. Currency figures normalised to Sonova Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

25.02%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price International Ltd.as of 15 Oct 20243.03m5.08%
Capital International Ltd.as of 10 Sep 20241.99m3.34%
MFS Institutional Advisors, Inc.as of 31 Mar 20241.85m3.10%
UBS Asset Management Switzerland AGas of 31 Mar 20241.83m3.06%
The Vanguard Group, Inc.as of 02 Oct 20241.68m2.82%
Norges Bank Investment Managementas of 30 Jun 20241.23m2.06%
BlackRock Fund Advisorsas of 03 Oct 2024962.53k1.61%
Capital Research & Management Co. (World Investors)as of 30 Sep 2024913.00k1.53%
BlackRock Advisors (UK) Ltd.as of 03 Oct 2024725.91k1.22%
MFS International (UK) Ltd.as of 30 Sep 2024714.19k1.20%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.